Literature DB >> 23086928

Ubiquitination of retinoblastoma family protein 1 potentiates gene-specific repression function.

Nitin Raj1, Liang Zhang, Yiliang Wei, David N Arnosti, R William Henry.   

Abstract

The retinoblastoma (RB) tumor suppressor family functions as a regulatory node governing cell cycle progression, differentiation, and apoptosis. Post-translational modifications play a critical role in modulating RB activity, but additional levels of control, including protein turnover, are also essential for proper function. The Drosophila RB homolog Rbf1 is subjected to developmentally cued proteolysis mediated by an instability element (IE) present in the C terminus of this protein. Paradoxically, instability mediated by the IE is also linked to Rbf1 repression potency, suggesting that proteolytic machinery may also be directly involved in transcriptional repression. We show that the Rbf1 IE is an autonomous degron that stimulates both Rbf1 ubiquitination and repression potency. Importantly, Rbf1 IE function is promoter-specific, contributing to repression of cell cycle responsive genes but not to repression of cell signaling genes. The multifunctional IE domain thus provides Rbf1 flexibility for discrimination between target genes embedded in divergent cellular processes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23086928      PMCID: PMC3516731          DOI: 10.1074/jbc.M112.422428

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Target gene specificity of E2F and pocket protein family members in living cells.

Authors:  J Wells; K E Boyd; C J Fry; S M Bartley; P J Farnham
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

2.  VP16 and ubiquitin; binding of P-TEFb via its activation domain and ubiquitin facilitates elongation of transcription of target genes.

Authors:  Takeshi Kurosu; B Matija Peterlin
Journal:  Curr Biol       Date:  2004-06-22       Impact factor: 10.834

3.  Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression.

Authors:  E S Knudsen; C Buckmaster; T T Chen; J R Feramisco; J Y Wang
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

Review 4.  Regulation of cell lineage specification by the retinoblastoma tumor suppressor.

Authors:  S X Skapek; Y-R Pan; E Y-H P Lee
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

Review 5.  Role of the retinoblastoma tumor suppressor protein in cellular differentiation.

Authors:  Don X Nguyen; Dennis J McCance
Journal:  J Cell Biochem       Date:  2005-04-01       Impact factor: 4.429

6.  The central acidic domain of MDM2 is critical in inhibition of retinoblastoma-mediated suppression of E2F and cell growth.

Authors:  Patima Sdek; Haoqiang Ying; Hongwu Zheng; Alexander Margulis; Xiaoren Tang; Kui Tian; Zhi-Xiong Jim Xiao
Journal:  J Biol Chem       Date:  2004-10-13       Impact factor: 5.157

7.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.

Authors:  P W Hinds; S Mittnacht; V Dulic; A Arnold; S I Reed; R A Weinberg
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

Review 8.  The COP9 signalosome: at the interface between signal transduction and ubiquitin-dependent proteolysis.

Authors:  Dawadschargal Bech-Otschir; Michael Seeger; Wolfgang Dubiel
Journal:  J Cell Sci       Date:  2002-02-01       Impact factor: 5.285

9.  p38 phosphorylates Rb on Ser567 by a novel, cell cycle-independent mechanism that triggers Rb-Hdm2 interaction and apoptosis.

Authors:  R B Delston; K A Matatall; Y Sun; M D Onken; J W Harbour
Journal:  Oncogene       Date:  2010-09-27       Impact factor: 9.867

10.  Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis.

Authors:  S E Salghetti; M Muratani; H Wijnen; B Futcher; W P Tansey
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  7 in total

1.  Rbf1 degron dysfunction enhances cellular DNA replication.

Authors:  Nitin Raj; Liang Zhang; Yiliang Wei; David N Arnosti; R William Henry
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

2.  The Evolutionarily Conserved C-terminal Domains in the Mammalian Retinoblastoma Tumor Suppressor Family Serve as Dual Regulators of Protein Stability and Transcriptional Potency.

Authors:  Satyaki Sengupta; Raj Lingnurkar; Timothy S Carey; Monica Pomaville; Parimal Kar; Michael Feig; Catherine A Wilson; Jason G Knott; David N Arnosti; R William Henry
Journal:  J Biol Chem       Date:  2015-04-22       Impact factor: 5.157

3.  Complex cis-regulatory landscape of the insulin receptor gene underlies the broad expression of a central signaling regulator.

Authors:  Yiliang Wei; Rewatee H Gokhale; Anne Sonnenschein; Kelly Mone't Montgomery; Andrew Ingersoll; David N Arnosti
Journal:  Development       Date:  2016-10-01       Impact factor: 6.868

4.  Integrated stability and activity control of the Drosophila Rbf1 retinoblastoma protein.

Authors:  Liang Zhang; Yiliang Wei; Irina Pushel; Karolin Heinze; Jared Elenbaas; R William Henry; David N Arnosti
Journal:  J Biol Chem       Date:  2014-07-21       Impact factor: 5.157

5.  Role of Drosophila retinoblastoma protein instability element in cell growth and proliferation.

Authors:  Jared S Elenbaas; Rima Mouawad; R William Henry; David N Arnosti; Sandhya Payankaulam
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  Genome-Wide Analysis of Drosophila RBf2 Protein Highlights the Diversity of RB Family Targets and Possible Role in Regulation of Ribosome Biosynthesis.

Authors:  Yiliang Wei; Shamba S Mondal; Rima Mouawad; Bartek Wilczyński; R William Henry; David N Arnosti
Journal:  G3 (Bethesda)       Date:  2015-05-20       Impact factor: 3.154

7.  Regulation of cell polarity determinants by the Retinoblastoma tumor suppressor protein.

Authors:  Sandhya Payankaulam; Kelvin Yeung; Helen McNeill; R William Henry; David N Arnosti
Journal:  Sci Rep       Date:  2016-03-14       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.